RUNX2 and cancer: Given that the Wnt/β‐catenin signaling pathway holds the key to the progress of a variety of diseases and cancers and RUNX2 could control bone resorption through the downregulation of the Wnt/β‐catenin signaling pathway in osteoblasts,30, 31 the part of RUNX2 played in the activity of Wnt/β‐catenin signaling pathway was examined.